United States
Premiumsupplier
Orelabrutinib CAS NO.1655504-04-3
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- ICP-022
- ICP 022
Quick Details
- ProName: Orelabrutinib
- CasNo: 1655504-04-3
- Molecular Formula: C26H25N3O3
- Application: For research use only.
- Purity: 95%
- LimitNum: 0
Superiority
We provide customized and high-quality Orelabrutinib product for your project.
Details
Orelabrutinib is an orally administered, potent, irreversible and highly selective BTK inhibitor. In December 2020, orelabrutinib received its first approval in China for the treatment of patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukaemia (CLL)/small lymphocytic lymphoma (SLL).
